We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
Cap. Flow
-$89M
Cap. Flow %
-1.11%
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.8M
2
PG icon
Procter & Gamble
PG
+$24.6M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$23.6M
4
KEYS icon
Keysight
KEYS
+$23.2M
5
BMY icon
Bristol-Myers Squibb
BMY
+$21.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$46.5M
2
XOM icon
ExxonMobil
XOM
+$36.6M
3
GG
Goldcorp Inc
GG
+$24.9M
4
DIS icon
Walt Disney
DIS
+$23.8M
5
NAVG
Navigators Group Inc
NAVG
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.16%
2 Technology 16.87%
3 Financials 10.38%
4 Consumer Discretionary 9.09%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INFY icon
151
Infosys
INFY
$45B
$12.7M 0.16%
1,191,046
+910,985
+325% +$9.65M
MGNX icon
152
MacroGenics
MGNX
$235M
$12.7M 0.16%
750,988
+85,500
+13% +$1.47M
ED icon
153
Consolidated Edison
ED
$41.6B
$12.6M 0.16%
144,378
-1,468
-1% -$126K
NKE icon
154
CALL
Nike
NKE
$61.9B
$12.5M 0.16%
+149,872
New +$12.6M
AMT icon
155
American Tower
AMT
$77.7B
$12.5M 0.16%
61,484
+16,131
+36% +$3.24M
SCCO icon
156
Southern Copper
SCCO
$141B
$12.4M 0.15%
345,188
-19,417
-5% -$676K
HRTX icon
157
Heron Therapeutics
HRTX
$86.3M
$12.4M 0.15%
668,600
+80,000
+14% +$1.6M
DAL icon
158
Delta Air Lines
DAL
$55.9B
$12.2M 0.15%
215,707
-93,937
-30% -$5.26M
COF icon
159
Capital One
COF
$124B
$12M 0.15%
133,004
-13,462
-9% -$1.2M
WBC
160
DELISTED
WABCO HOLDINGS INC.
WBC
$12M 0.15%
90,940
+43,000
+90% +$5.67M
BEN icon
161
Franklin Resources
BEN
$16.9B
$12M 0.15%
345,267
-88,354
-20% -$3M
DATA
162
DELISTED
Tableau Software, Inc.
DATA
$11.9M 0.15%
+71,902
New +$9.45M
ON icon
163
ON Semiconductor
ON
$33.8B
$11.9M 0.15%
+590,554
New +$12.2M
AMD icon
164
Advanced Micro Devices
AMD
$851B
$11.7M 0.15%
387,217
-10,054
-3% -$287K
KPTI icon
165
Karyopharm Therapeutics
KPTI
$168M
$11.6M 0.14%
129,785
+5,333
+4% +$428K
VSM
166
DELISTED
Versum Materials, Inc.
VSM
$11.4M 0.14%
222,816
+91,976
+70% +$4.75M
ISRG icon
167
Intuitive Surgical
ISRG
$121B
$11.4M 0.14%
65,208
-51,714
-44% -$8.86M
BOLD
168
DELISTED
Audentes Therapeutics, Inc
BOLD
$11.3M 0.14%
300,800
– –
CI icon
169
Cigna
CI
$76.6B
$11.3M 0.14%
72,072
-20,945
-23% -$3.28M
LW icon
170
Lamb Weston
LW
$6.82B
$11.2M 0.14%
177,850
+160,649
+934% +$10.6M
ZGNX
171
DELISTED
Zogenix, Inc.
ZGNX
$11.2M 0.14%
235,700
– –
ANET icon
172
Arista Networks
ANET
$219B
$11.2M 0.14%
693,120
-3,056
-0.4% -$52.9K
ZBRA icon
173
Zebra Technologies
ZBRA
$12.4B
$11.2M 0.14%
53,682
+37,413
+230% +$7.54M
HLT icon
174
Hilton Worldwide
HLT
$74B
$11.1M 0.14%
101,476
+82,098
+424% +$7.45M
WFC icon
175
Wells Fargo
WFC
$261B
$11.1M 0.14%
156,556
-324,665
-67% -$15.2M
5 6
7
8 9

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2019 Portfolio in Review

As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
  • Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
  • Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
  • Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
  • Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
  • Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
  • Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.